Skip to main content
Premium Trial:

Request an Annual Quote

Agilent Posts 19 Percent Jump in Q1 Life Sciences Revenues Driven by LC, Mass Spec Sales

Premium

Agilent Technologies this week posted a 25 percent year-over-year increase in revenues for the first quarter of 2011, including a 19 percent rise in revenues in its Life Sciences segment.

The Life Sciences jump was driven by strong sales in liquid chromatography and mass spectrometry platforms due in part to an acceleration in the instrument replacement cycle, CEO Bill Sullivan said on an investor call discussing the company's earnings.

Nick Roelofs, president of Agilent's Life Sciences group, cited in particular an increase in "big pharma replacing instrumentation" as a factor in the division's strong showing, noting that the company expects that replacement cycle "will continue now for another two years."

Roelofs also provided commentary on how current US federal budget battles might affect instrument purchases in the near term, predicting that NIH funding for research in –omics fields like genomics and proteomics wouldn't be affected.

For the three months ended Jan. 31, overall revenues were $1.52 billion, up from $1.21 billion in the first quarter of 2010. Life Sciences revenues were $404 million, up from $340 million a year ago.

Net income was $193 million, or $0.54 per share, up 144 percent compared to $79 million, or $0.22 per share, a year ago.

R&D spending in the quarter rose to $159 million, up 7 percent from $149 million.

As of Jan. 31, the company had $2.64 billion in cash and cash equivalents.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.